thromboxane-a2 has been researched along with Cushing-Syndrome* in 1 studies
1 other study(ies) available for thromboxane-a2 and Cushing-Syndrome
Article | Year |
---|---|
Haemostatic parameters in Cushing's syndrome.
We have studied haemostatic parameters in 12 patients with Cushing's syndrome. Three patients had prolonged bleeding times, and in all seven patients whose bleeding times were measured 3-6 months after surgical treatment the postoperative bleeding times were shorter (mean 7.5 min) than the pretreatment times (mean 12.3 min). In ADP- or adrenaline-induced aggregation the second wave was lacking in six and the degree of aggregation was borderline or subnormal in five patients. One patient had, in addition, a severe defect in collagen-induced aggregation. However, thromboxane B2 production of the platelets from both endogenous and exogenous arachidonic acid was unaffected. Factor VIII:C, RAg and Rcof activities were all elevated, and in patients with severe disease F VIIIR:Ag and F VIII:Rcof activities were markedly more elevated than F VIII:C activity. The changes in both primary haemostasis and in factor VIII activities correlated clearly with the clinical severity of the disease. Topics: Adolescent; Adult; Bleeding Time; Blood Platelets; Cushing Syndrome; Female; Hemostasis; Humans; Male; Platelet Aggregation; Thromboxane A2; Thromboxane B2; Thromboxanes | 1985 |